UnknownNot Applicable

The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma

60 participantsStarted 2022-04-01

Plain-language summary

The aim of this prospective cohort study is to explore the clinical significance of sentinel lymph node imaging combined imaging examination evaluation in pelvic and peritoneal lymphadenectomy for endometrial carcinoma management.

Who can participate

Age range

10 Years – 90 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Females who are diagnosed with endometrial carcinoma;
. Patients who are willing to receive primary non-reserved fertility function surgery to treat their disease;
. Patients who are agreed to participated in this prospective cohort study.

Exclusion criteria

. Patients who still have the will to have pregnancy;
. Patients who have other diseases or heavy injuries that will interfere with the results;
. Simultaneous participation in another clinical study with investigational medicinal product(s) or researcher thinks the subjects are not suitable for this trial.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

the number (s) of pelvic and abdominal lymph node metastasis

Timeframe: 1 year during the perioperative period

the percentage (%) of pelvic and abdominal lymph node metastasis

Timeframe: 1 year during the perioperative period

the coincidence rate (%) of pelvic and abdominal lymph node imaging, sentinel lymph node imaging and pathological diagnosis

Timeframe: 1 year during the perioperative period

the effect of pelvic lymphadenectomy on the prognosis of endometrial carcinoma patients

Timeframe: 1 year during the perioperative period

Trial details

NCT IDNCT03877627

SponsorSecond Affiliated Hospital of Wenzhou Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-15

Contact for this trial

Yu ZHAO, Ph.D

13777760306 zhaoyu196035@163.com

View on ClinicalTrials.gov More Endometrial Carcinoma trials

Who can participate

Age range

10 Years – 90 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Females who are diagnosed with endometrial carcinoma;
. Patients who are willing to receive primary non-reserved fertility function surgery to treat their disease;
. Patients who are agreed to participated in this prospective cohort study.

Exclusion criteria

. Patients who still have the will to have pregnancy;
. Patients who have other diseases or heavy injuries that will interfere with the results;
. Simultaneous participation in another clinical study with investigational medicinal product(s) or researcher thinks the subjects are not suitable for this trial.

What they're measuring

the number (s) of pelvic and abdominal lymph node metastasis

Timeframe: 1 year during the perioperative period

the percentage (%) of pelvic and abdominal lymph node metastasis

Timeframe: 1 year during the perioperative period

the coincidence rate (%) of pelvic and abdominal lymph node imaging, sentinel lymph node imaging and pathological diagnosis

Timeframe: 1 year during the perioperative period

the effect of pelvic lymphadenectomy on the prognosis of endometrial carcinoma patients

Timeframe: 1 year during the perioperative period